For technology licensing inquiries, please contact Nicholas A. Boyle at email@example.com.
Previously, Nicholas was Director of Corporate Development at Spectrum Pharmaceuticals Inc. Among other responsibilities at Spectrum, Nicholas completed numerous strategic licensing agreements, was responsible for Alliance Management, and was Project Leader for a Phase III cancer compound.
During his scientific career, Nicholas was Team Leader for antiviral and anticancer drug discovery programs at Biota Inc. and synthesized anti-stroke drug candidates at SmithKline Beecham (now GSK). Nicholas is an author/inventor on 15 scientific articles/patents.
Nicholas holds an MBA from the University of California San Diego (UCSD), a Ph.D. in organic chemistry from Sheffield University, and a BSc (Hons) in Medicinal Chemistry. He completed his Post-Doctoral research at The Scripps Research Institute, was a visiting scholar at The University of North Texas and received a Monbusho Fellowship to conduct research at NIAIR, Tsukuba, Japan.